Search Within

Malcolm A S Moore

  1. "Breast Medicine Service"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (9)
Groups
  1. Breast Medicine Service (20)
  2. Cell Biology Program Faculty (20)
  3. Department of Medicine (20)
  4. Sloan Kettering Institute Faculty (20)
  5. Solid Tumor Oncology Division (20)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (12)

More Groups

People
  1. Larry Norton (12)
  2. Lilian Reich (12)
  3. Jeffrey Schneider (11)
  4. John Crown (9)
  5. David Fennelly (8)
  6. Fred Shapiro (7)

More People

Years
  1. 2015 (1)
  2. 2000 (1)
  3. 1999 (1)
  4. 1998 (1)
  5. 1997 (4)
  6. 1995 (2)

More Years

Publications
  1. Blood (8)
  2. Clinical Cancer Research (2)
  3. Journal of Clinical Oncology (2)
  4. Bone Marrow Transplantation (1)
  5. Cancer (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. American Association for Cancer Research (4)
  3. American Society of Clinical Oncology (2)
  4. Nature Publishing Group (2)
  5. Elsevier B.V. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
    Meeting Abstract

    Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture
    Journal Article

    Engelhardt, M.; Mackenzie, K.; Drullinsky, P.; Silver, R. T.; Moore, M. A. S.
    Cancer Research (2000)

    Fulltext@MSK | Save
  • Stem cell rescue after bone marrow curettage for the treatment of myelofibrosis with myeloid metaplasm myeloproliferative disorders
    Meeting Abstract

    Silver, R. T.; Moore, M. A. S.; Athanasian, E.; Schuster, M. W.; Gulati, S.; Clarke, B.; Dang, C.; Berk, G.
    Blood (1999)

    Fulltext@MSK | Save
  • Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy
    Journal Article

    Engelhardt, M.; Ozkaynak, M. F.; Drullinsky, P.; Sandoval, C.; Tugal, O.; Jayabose, S.; Moore, M. A. S.
    Leukemia (1998)

    Fulltext@MSK | Save
  • Telomerase activity and telomere length in CD34+ cells from acute and chronic leukemias, pre- and post-ex vivo expansion
    Meeting Abstract

    Engelhardt, M.; Silver, R. T.; Drullisky, P.; Moore, M. A. S.
    Experimental Hematology (1997)

    Fulltext@MSK | Save
  • Telomerase activity and telomere length in healthy donors and patients with leukemia, pre- and post-ex vivo expansion
    Meeting Abstract

    Engelhardt, M.; Silver, R. T.; Drullisky, P.; Moore, M. A. S.
    Blood (1997)

    Fulltext@MSK | Save
  • Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma
    Journal Article

    Engelhardt, M.; Albanell, J.; Drullinsky, P.; Han, W.; Guillem, J.; Scher, H. I.; Reuter, V.; Moore, M. A. S.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save
  • Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer
    Journal Article

    Engelhardt, M.; Drullinsky, P.; Guillem, J.; Moore, M. A. S.
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save
  • Rapid hematologic recovery following CD34+ selected versus unselected peripheral blood progenitor cell (PBPC) plus filgrastim (G) rescue of sequential high dose chemotherapy (HDC) in patients (PTS) with metastatic breast cancer (MBC)
    Meeting Abstract

    Raptis, G.; Tiersten, A.; Shapiro, F.; Schneider, J.; Hamilton, N.; Reich, L.; Wuest, D.; Gucciardo, A.; Quiguyan, L.; Gilewski, T.; more...
    Blood (1995)

    Fulltext@MSK | Save
  • Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses
    Journal Article

    Fennelly, D.; Schneider, J.; Spriggs, D.; Bengala, C.; Hakes, T.; Reich, L.; Barakat, R.; Curtin, J.; Moore, M. A. S.; Hoskins, W.; more...
    Journal of Clinical Oncology (1995)

    Fulltext@MSK | Save